Clinical Evidence Supporting the Role of DOPTELET…
Loading Map....
Clinical Evidence Supporting the Role of DOPTELET® (avatrombopag) for Adult Patients with Chronic Immune
Thrombocytopenia (ITP) Who Have Had an Insufficient Response to a Previous Treatment
Presented by
Misty Mahaffey, BSN, MS, RN
Oncology Nurse
Advanced Practice Provider, Hematology
Stanford Health Care
RSVP by January 10th to:
Email: Lkarrer@dova.com
Phone: 650-880-0456
Fax: 886-730-5281